Federal drug authorities issued a warning Tuesday to one of the largest cannabis companies in the U.S. for how it is marketing and selling its CBD products. The U.S. Food and Drug Administration (FDA) sent a warning letter to Curaleaf, a vertically integrated marijuana and hemp company based in Wakefield, Massachusetts. The FDA accused Curaleaf […]Read More
A California CBD company that makes infused olive oils has bought a smaller chocolate company with distribution in traditional grocers such as Whole Foods Market. Gabriella’s Kitchen bought Lulu’s Chocolates of Nevada City, California, for $1 million in stock. Margot Micallef, CEO of Gabriella’s Kitchen, told Hemp Industry Daily the acquisition positions her company for distribution […]Read More
A former U.S. surgeon general is joining the advisory board of a California CBD company. Dr. Richard Carmona, who served as surgeon general from 2002 to 2008, will advise Kadenwood, a privately held company that makes topical CBD products in Newport Beach, California. The appointment gives Kadenwood a government insider to “shift the perception of […]Read More
A surge in academic research about hemp-derived cannabinoids is giving CBD companies new opportunities to find university partners to validate mountains of anecdotal evidence about cannabidiol’s health benefits. The research boom is enabled by hemp’s new legal status and funded by cannabis entrepreneurs who see an opportunity to bring a stamp of authority to an […]Read More
A Canadian marijuana producer cited hemp and CBD’s potential in Europe as it announced plans to acquire a smaller Canadian company with a CBD subsidiary in the Netherlands. The announcement Wednesday that Toronto-based Supreme Cannabis plans to acquire Truverra underscores the interest in accessing European markets. Supreme valued the acquisition at roughly $20 million. Supreme […]Read More
European hemp producers and manufacturers are getting renewed pleas to help fight the European Union on how it treats CBD and other extracts. The European Industrial Hemp Association (EIHA) sent an alert this week to roughly 300 members urging the EU to change its Common Agricultural Policy, which governs food rules, according to Hemp Today. The […]Read More
U.S. health authorities are taking final comments from the public on how to regulate over-the-counter cannabis extracts such as CBD. The suggestions are due to the U.S. Food and Drug Administration (FDA) by midnight ET Tuesday, July 16, on how the agency should regulate cannabis-derived products. The FDA has vowed to expedite its review of cannabis-derived compounds […]Read More
Federal health regulators say they’ll update the hemp industry on their CBD review by late summer or fall. Dr. Amy Abernethy, who leads the U.S. Food and Drug Administration’s work group on cannabinoids such as CBD, said Friday the agency is “enthusiastic about research into the therapeutic benefits of CBD products but also need to balance […]Read More
Sol Global, a Toronto-based international cannabis investment firm, has increased its stake in a privately held CBD company. The firm announced Friday it spent 15 million Canadian dollars ($11.5 million) in HeavenlyRx. The purchase brings Sol Global to a 42% stake in HeavenlyRx. The announcement comes less than a week after Sol Global raised CA$50 […]Read More
A Toronto-based hemp and CBD investment company increased its stake in a traditional soda company with an eye toward developing CBD-infused beverages with the brand. HeavenlyRx bought 15 million shares in Jones Soda Co. for $9 million and now holds 39% of the Seattle-based beverage manufacturer. The deal also gives HeavenlyRx two seats on Jones Soda’s board. Jones […]Read More
California-based Demetrix secured $50 million in a Series A funding, which the company will use for research of synthetic cannabinoid production. The Emeryville company wants to use baker’s yeast to produce large volumes of cannabinoids. More than 100 of cannabinoids can be found in the cannabis plant, sometimes in trace amounts. The company did not […]Read More
Data from Gallup shows that younger Americans are more confident in the health benefits of CBD – but the majority of people familiar with cannabinoids, regardless of age, believe it has at least some health benefits. A telephone poll conducted by Gallup in late May found that 78% of surveyed individuals across the United States […]Read More
Laura Drotleff Interviews Dr. Jonathan Vaught, CEO & Founder of Front Range BiosciencesHemp Industry Daily reporter, Laura Drotleff, interviews Dr. Jonathan Vaught, CEO & Founder of Front Range Biosciences.
Monica Raymunt Interviews Giovanni Isoldi, CTO at Materia Medica ProcessingHemp Industry Daily international reporter, Monica Raymunt, interviews Giovanni Isoldi, CTO at Materia Medica Processing.
Starting a CBD Business During a Time of UncertaintyThe economy has seen its fair share of up’s and down’s, but the CBD industry, still in infancy, has been a wild ride. The CBD industry has been the mecca for business entrepreneurs and start-ups, but what happens when economic or environmental circumstances out of your control strike? Hemp Industry Daily reporter Ivan Moreno, speaks with Jennifer Culpepper, Founder and Principal at Brand Joint and Co-founder at I+I Botanicals, and Christopher Gavigan, Founder and CEO at Prima, to discuss their experience during COVID-19.